{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:57:05Z","timestamp":1785765425956,"version":"3.56.0"},"reference-count":87,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA050540"],"award-info":[{"award-number":["R01DA050540"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"award":["R01DA050540"],"award-info":[{"award-number":["R01DA050540"]}],"id":[{"id":"https:\/\/ror.org\/00fq5cm18","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes an immune-mediated neurological syndrome, which persists long after infection. Mechanisms for SARS-CoV-2-associated neurological complications are multifactorial, with an increased risk of drug abuse such as methamphetamine (meth). SARS-CoV-2 infection and its viral proteins play pivotal roles in coronavirus disease 2019 (COVID-19)-associated neuroinflammation, which can lead to long COVID. We hypothesize that meth augments activation of the microglial NOD-, leucine-rich repeat, and pyrin domain-containing protein 3 (NLRP3) inflammasome by the SARS-CoV-2 nucleocapsid (N) protein, resulting in neuroinflammation. To test this hypothesis, we investigated the effect of N-protein and meth on NLRP3 inflammasome activation in primary rat microglial cultures using enzyme-linked immunosorbent assay (ELISA), Reverse Transcription quantitative Polymerase Chain reaction (RT-qPCR), western blot (WB), and immunofluorescence assay (IFA). Our results showed that meth augmented N-protein-induced microglial activation, as evidenced by increased ionized calcium-binding adapter 1 (Iba-1) expression. The addition of meth to the microglial cultures treated with N-protein increased proinflammatory cytokine production. Meth augmentation of N-protein-induced neuroinflammation was further supported by increased inducible nitric oxide synthase (iNOS)-mediated nitric oxide (NO) production. The effects of meth on N-protein-associated inflammatory responses were significantly attenuated by MCC950, a specific NLRP3 inhibitor. Moreover, meth-associated NLRP3 activation was either blocked by the opioid sigma1-receptor (\u03c31-R) inhibitor BD1047 or by \u03c31R siRNA knockdown. Taken together, these results demonstrated that meth augmented SARS-CoV-2 N-protein-induced neuroinflammation via microglial \u03c31-R and the NLRP3 inflammasome, which may underlie the pathogenesis of neurological manifestations in COVID-19, such as long COVID with meth abuse. These results may also underscore the impact of drug abuse on long COVID and provide targets for the development of therapeutic strategies to control the neurological outcomes of long COVID.<\/jats:p>","DOI":"10.3390\/ijms27156960","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:57:56Z","timestamp":1785761876000},"page":"6960","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Involvement of NLRP3 Inflammasome in Methamphetamine Augmentation of SARS-CoV-2 N-Protein-Induced Neuroinflammation in Rat Microglial Cells"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6038-2416","authenticated-orcid":false,"given":"Debashis","family":"Dutta","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianuo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3450-8876","authenticated-orcid":false,"given":"Huangui","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020). The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol., 5, 536\u2013544.","DOI":"10.1038\/s41564-020-0695-z"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jmv.25766","article-title":"Coronavirus disease 2019: What we know?","volume":"92","author":"He","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"114032","DOI":"10.1016\/j.jviromet.2020.114032","article-title":"Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses","volume":"289","author":"Chen","year":"2021","journal-title":"J. Virol. Methods"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(20)30557-2","article-title":"SARS-CoV-2 is an appropriate name for the new coronavirus","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First Case of 2019 Novel Coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_9","unstructured":"World Health Organization (2026, June 07). Coronavirus Disease (COVID-19). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/coronavirus-disease-%28covid-19%29."},{"key":"ref_10","first-page":"5","article-title":"Understanding COVID-19: The virus","volume":"33","author":"Hoffman","year":"2020","journal-title":"Community Eye Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","article-title":"The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections","volume":"15","author":"Machhi","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(20)31142-9","article-title":"COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis","volume":"395","author":"Chu","year":"2020","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0140-6736(20)31183-1","article-title":"Physical distancing, face masks, and eye protection for prevention of COVID-19","volume":"395","author":"MacIntyre","year":"2020","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"118054","DOI":"10.1016\/j.lfs.2020.118054","article-title":"Tackling the cytokine storm in COVID-19, challenges and hopes","volume":"257","author":"Abdin","year":"2020","journal-title":"Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Polidoro, R.B., Hagan, R.S., de Santis Santiago, R., and Schmidt, N.W. (2020). Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01626"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e20200678","DOI":"10.1084\/jem.20200678","article-title":"The many faces of the anti-COVID immune response","volume":"217","author":"Vardhana","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_18","first-page":"138","article-title":"NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes","volume":"14","author":"Dutta","year":"2022","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13195-020-00640-3","article-title":"Immediate and long-term consequences of COVID-19 infections for the development of neurological disease","volume":"12","author":"Heneka","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e0013124","DOI":"10.1128\/cmr.00131-24","article-title":"Neurological complications caused by SARS-CoV-2","volume":"37","author":"Pang","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41583-023-00769-8","article-title":"The neurobiology of SARS-CoV-2 infection","volume":"25","author":"Meinhardt","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11033-024-09279-x","article-title":"COVID-19 and the brain: Understanding the pathogenesis and consequences of neurological damage","volume":"51","author":"Maliha","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Proal, A.D., and VanElzakker, M.B. (2021). Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.698169"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"20406223221076890","DOI":"10.1177\/20406223221076890","article-title":"Neurological manifestations of long-COVID syndrome: A narrative review","volume":"13","author":"Stefanou","year":"2022","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41582-026-01205-y","article-title":"Understanding the long-term neurological effects of SARS-CoV-2 infection","volume":"22","author":"Matthews","year":"2026","journal-title":"Nat. Rev. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14737175.2024.2440543","article-title":"Tackling persistent neurological symptoms in patients following acute COVID-19 infection: An update of the literature","volume":"25","author":"Divani","year":"2025","journal-title":"Expert Rev. Neurother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","article-title":"Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review","volume":"226","author":"Chen","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12015-020-10010-z","article-title":"SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45\u2212 Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome","volume":"17","author":"Ratajczak","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e20201707","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12964-023-01397-6","article-title":"SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells","volume":"22","author":"Villacampa","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41420-024-01966-9","article-title":"SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1\u03b1 in pulmonary epithelial and endothelial cells","volume":"10","author":"Kozlowski","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Guarnieri, J.W., Angelin, A., Murdock, D.G., Schaefer, P., Portluri, P., Lie, T., Huang, J., and Wallace, D.C. (2023). SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1064293"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12035-021-02593-6","article-title":"SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia","volume":"59","author":"Olajide","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10753-021-01464-5","article-title":"Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone","volume":"44","author":"Olajide","year":"2021","journal-title":"Inflammation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/s41467-021-25015-6","article-title":"SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation","volume":"12","author":"Pan","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cytogfr.2021.06.002","article-title":"The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies","volume":"61","author":"Zhao","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/qjmed\/hcad011","article-title":"NLRP3, the inflammasome and COVID-19 infection","volume":"116","author":"Yin","year":"2023","journal-title":"QJM Int. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e28751","DOI":"10.1002\/jmv.28751","article-title":"The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection","volume":"95","author":"Qudus","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1038\/s41380-022-01831-0","article-title":"SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein","volume":"28","author":"Albornoz","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41467-025-56097-1","article-title":"Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1beta-independent neutrophil chemotaxis upon peripheral inflammation in mice","volume":"16","author":"Yoon","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41419-026-08424-7","article-title":"Mitochondrial DNA drives NLRP3-IL-1beta axis activation in microglia by binding to NLRP3, leading to neurodegeneration in Parkinson\u2019s disease models","volume":"17","author":"Gan","year":"2026","journal-title":"Cell Death Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"111532","DOI":"10.1016\/j.celrep.2022.111532","article-title":"Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like mice","volume":"41","author":"Li","year":"2022","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12967-026-07703-3","article-title":"The NLRP3 inflammasome as a key pathway in the affective and chronic fatigue symptoms of Long COVID","volume":"24","author":"Zhang","year":"2026","journal-title":"J. Transl. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","article-title":"NLRP3 inflammasome in neuroinflammation and central nervous system diseases","volume":"22","author":"Xu","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jmv.25915","article-title":"Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","volume":"92","author":"Bryce","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"577728","DOI":"10.1016\/j.jneuroim.2021.577728","article-title":"The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases","volume":"361","author":"Cama","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41570-022-00413-6","article-title":"Tiny but bright","volume":"6","author":"Nagai","year":"2022","journal-title":"Nat. Rev. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"m313","DOI":"10.1136\/bmj.m313","article-title":"The psychological effects of quarantining a city","volume":"368","author":"Rubin","year":"2020","journal-title":"BMJ"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"106754","DOI":"10.1016\/j.addbeh.2020.106754","article-title":"Substance use and abuse, COVID-19-related distress, and disregard for social distancing: A network analysis","volume":"114","author":"Taylor","year":"2021","journal-title":"Addict. Behav."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/29767342251370454","article-title":"Substance Use During the COVID-19 Pandemic in the Americas: A Scoping Review","volume":"47","author":"Sanchez","year":"2026","journal-title":"Subst. Use Addctn. J."},{"key":"ref_53","first-page":"165","article-title":"Inflammasome in drug abuse","volume":"9","author":"Xu","year":"2017","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sil, S., Niu, F., Chivero, E.T., Singh, S., Periyasamy, P., and Buch, S. (2020). Role of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging. Cells, 9.","DOI":"10.3390\/cells9081857"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Guo, M.L., Roodsari, S.K., Cheng, Y., Dempsey, R.E., and Hu, W. (2023). Microglia NLRP3 Inflammasome and Neuroimmune Signaling in Substance Use Disorders. Biomolecules, 13.","DOI":"10.3390\/biom13060922"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/nipt-2023-0004","article-title":"Substances of abuse and their effect on SAR-CoV-2 pathogenesis","volume":"2","author":"Antwi","year":"2023","journal-title":"Neuroimmune Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Theoharides, T.C., and Kempuraj, D. (2023). Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID. Cells, 12.","DOI":"10.3390\/cells12050688"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100888","DOI":"10.1016\/j.bbih.2024.100888","article-title":"SARS-CoV-2 infection in microglia and its sequelae: What do we know so far?","volume":"42","author":"Luo","year":"2024","journal-title":"Brain Behav. Immun.-Health"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00439-023-02549-x","article-title":"Direct and indirect impact of SARS-CoV-2 on the brain","volume":"142","author":"Peron","year":"2023","journal-title":"Hum. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"102608","DOI":"10.1016\/j.conb.2022.102608","article-title":"Neuroinflammation and COVID-19","volume":"76","author":"Vanderheiden","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Dutta, D., Liu, J., Xu, E., and Xiong, H. (2024). Methamphetamine Enhancement of HIV-1 gp120-Mediated NLRP3 Inflammasome Activation and Resultant Proinflammatory Responses in Rat Microglial Cultures. Int. J. Mol. Sci., 25.","DOI":"10.21203\/rs.3.rs-3707515\/v1"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11481-018-9780-y","article-title":"Inflammasome Activation by Methamphetamine Potentiates Lipopolysaccharide Stimulation of IL-1beta Production in Microglia","volume":"13","author":"Xu","year":"2018","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"C327","DOI":"10.1152\/ajpcell.1998.275.2.C327","article-title":"Ion channels in microglia (brain macrophages)","volume":"275","author":"Eder","year":"1998","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Cocozza, G., Garofalo, S., Capitani, R., D\u2019Alessandro, G., and Limatola, C. (2021). Microglial Potassium Channels: From Homeostasis to Neurodegeneration. Biomolecules, 11.","DOI":"10.3390\/biom11121774"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jemt.1117","article-title":"Ion channels in cultured microglia","volume":"54","author":"Walz","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0306-4522(94)00398-O","article-title":"Cytokine-dependent K+ channel profile of microglia at immunologically defined functional states","volume":"64","author":"Fischer","year":"1995","journal-title":"Neuroscience"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/19336950.2017.1300738","article-title":"Potassium channel expression and function in microglia: Plasticity and possible species variations","volume":"11","author":"Nguyen","year":"2017","journal-title":"Channels"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mcn.2017.05.009","article-title":"Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current","volume":"82","author":"Liu","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41392-021-00818-7","article-title":"Neurological complications and infection mechanism of SARS-COV-2","volume":"6","author":"Wan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12974-020-01896-0","article-title":"Central nervous system complications associated with SARS-CoV-2 infection: Integrative concepts of pathophysiology and case reports","volume":"17","author":"Najjar","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.17305\/bjbms.2022.7762","article-title":"SARS-CoV-2 infection and multi-organ system damage: A review","volume":"23","author":"Rabaan","year":"2023","journal-title":"Biomol. Biomed."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: A clinical update","volume":"404","author":"Greenhalgh","year":"2024","journal-title":"Lancet"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","article-title":"Mechanisms of long COVID and the path toward therapeutics","volume":"187","author":"Peluso","year":"2024","journal-title":"Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Davis","year":"2024","journal-title":"Nat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12941-025-00793-9","article-title":"Long COVID clinical evaluation, research and impact on society: A global expert consensus","volume":"24","author":"Ewing","year":"2025","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: Major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1473-3099(24)00216-0","article-title":"Long COVID and SARS-CoV-2 persistence: New answers, more questions","volume":"24","author":"Buonsenso","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Talkington, G.M., Kolluru, P., Gressett, T.E., Ismael, S., Meenakshi, U., Acquarone, M., Solch-Ottaiano, R.J., White, A., Ouvrier, B., and Par\u00e9, K. (2025). Neurological sequelae of long COVID: A comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1465787"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e70009","DOI":"10.1002\/rmv.70009","article-title":"Neuroinflammation in Post COVID-19 Sequelae: Neuroinvasion and Neuroimmune Crosstalk","volume":"34","author":"Selvam","year":"2024","journal-title":"Rev. Med. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Menezes, F., Palmeira, J.D.F., Oliveira, J.D.S., Arganaraz, G.A., Soares, C.R.J., Nobrega, O.T., Ribeiro, B.M., and Arganaraz, E.R. (2024). Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC. Front. Cell. Neurosci., 18.","DOI":"10.3389\/fncel.2024.1481963"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s12035-021-02696-0","article-title":"Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?","volume":"59","author":"Theoharides","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e0201225","DOI":"10.1128\/mbio.02012-25","article-title":"COVID-19-associated neuroinflammation and astrocyte death in the brain linked to ORF3a-induced activation of Sur1-mediated ion channels","volume":"16","author":"Gerzanich","year":"2025","journal-title":"mBio"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"102474","DOI":"10.1016\/j.mib.2024.102474","article-title":"Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection","volume":"79","author":"Jagst","year":"2024","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Zhao, C., and Zhao, W. (2020). NLRP3 Inflammasome-A Key Player in Antiviral Responses. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00211"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-021-00742-w","article-title":"A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-023-00674-9","article-title":"Microglial function, INPP5D\/SHIP1 signaling, and NLRP3 inflammasome activation: Implications for Alzheimer\u2019s disease","volume":"18","author":"Terzioglu","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1038\/cddis.2011.140","article-title":"Involvement of Kv1.3 and p38 MAPK signaling in HIV-1 glycoprotein 120-induced microglia neurotoxicity","volume":"3","author":"Liu","year":"2012","journal-title":"Cell Death Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6960\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:12:05Z","timestamp":1785762725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":87,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27156960"],"URL":"https:\/\/doi.org\/10.3390\/ijms27156960","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}